Keynote comment: Challenges of teenage and young-adult oncology

Lancet Oncology

Volumn 7, Issue 8, 2006, Pages 612-613

  Eden, Tim ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTOSINE; STEROID; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APOPTOSIS; BONE MARROW TRANSPLANTATION; CANCER DIAGNOSIS; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL PROTOCOL; CLINICAL TRIAL; ENVIRONMENTAL FACTOR; EWING SARCOMA; GENE MUTATION; GERM CELL TUMOR; HEALTH CARE UTILIZATION; HEALTH SERVICE; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALIGNANT NEOPLASTIC DISEASE; OSTEOSARCOMA; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SYMPTOM; UNITED KINGDOM; UNITED STATES;

ADOLESCENT; ADULT; HUMANS; NEOPLASMS; RESEARCH;

EID: 33746435842     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70769-0     Document Type: Letter

References (6)

1. In: Eden T., Barr R., Bleyer A., and Whiteson M. (Eds). Cancer and the adolescent, 2nd edn (2005), Blackwell Publishing/BMJ Books, Oxford
2. Birch J., Alston R., Quinn M., and Kelsey A. Incidence of malignant disease by morphological type in young persons aged 12-24 years in England 1979-1997. Eur J Cancer 39 (2003) 2622-2631
3. Goyal S., Roscoe J., Ryder W., et al. Symptom interval in young people with bone cancer. Eur J Cancer 40 (2004) 2280-2286
4. Nachman J. Leukaemia. Cancer and the adolescent. 2nd edn. (2005), Blackwell Publishing/BMJ Books, Oxford 61-71
5. Chessells J., Hall E., Prentice H., et al. The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC paediatric and adult working party. Leukemia 12 (1998) 463-473
6. National Institute for Health and Clinical Excellence. Improving outcomes in children and young people with cancer: guidance on cancer services. http://www.nice.org.uk/page.aspx?o=csgcyp (accessed July 10, 2006)